Atossa Genetics to Present at Two Upcoming Investor Conferences
January 09, 2014 16:01 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwired - Jan 9, 2014) - Atossa Genetics, Inc. (NASDAQ: ATOS), the Breast Health Company™, today announced that management will present at two upcoming investor conferences:...
Atossa Genetics to Present at the 2013 Aegis Capital Healthcare Conference
September 24, 2013 10:30 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwired - Sep 24, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company™, announced today that Kyle Guse, Chief Financial Officer & General Counsel,...
Atossa Genetics to Exhibit Its ForeCYTE Breast Health Test at the Pri-Med East 2013 Conference & Exhibition
September 19, 2013 08:30 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwired - Sep 19, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company™, will display its ForeCYTE Breast Health Test at the Pri-Med East 2013 Conference...
Atossa Genetics Signs Distribution Agreement With McKesson Medical-Surgical
September 18, 2013 08:30 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwired - Sep 18, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company™, announced today that it has entered into a nationwide distribution agreement with...
Atossa Genetics Featured on FoxNews.com
September 12, 2013 11:17 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwired - Sep 12, 2013) - The ForeCYTE Breast Health Test, the flagship product of Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company™, was featured in a video...
Atossa Genetics to Exhibit Its ForeCYTE Breast Health Test at the Breast Cancer Symposium 2013
September 06, 2013 08:30 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwired - Sep 6, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company™, will display its ForeCYTE Breast Health Test at the 7th annual Breast Cancer...
Atossa Genetics and Its Subsidiary the National Reference Laboratory for Breast Health to Exhibit Their Products and Services at Two Upcoming Conferences
August 21, 2013 17:29 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwired - Aug 21, 2013) - Atossa Genetics Inc. (NASDAQ: ATOS) and its subsidiary The National Reference Laboratory for Breast Health (NRLBH), will display their products and...
Atossa Genetics Reports Second Quarter 2013 Results and Operating Highlights
August 14, 2013 16:01 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwired - Aug 14, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), the Breast Health Company™, today announced its second quarter 2013 financial results and corporate...
Atossa Genetics to Announce Second Quarter 2013 Results on Wednesday, August 14, 2013
August 06, 2013 16:01 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwired - Aug 6, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company™, today announced that it will issue financial results and corporate highlights for...
New ASCO Clinical Practice Guideline for Breast Cancer Risk Reduction May Be Insufficient for Widespread Reduction, Atossa Genetics Says
August 05, 2013 08:30 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwired - Aug 5, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company™, said that the new ASCO clinical practice guideline for the use of pharmacologic...